Aquestive Therapeutics Inc.
AQST | NASDAQ
$4.78
+$0.17 (+3.69%)
At close: Sep 21, 2026, 4:00 PM ET
$4.74
-$0.04 (-0.84%)
After-hours:
Sep 21, 2026, 7:59 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 54.09M | 50.27M | 44.55M | 43.4M | 44.13M | 54.23M | 57.56M | 58.9M | 58.36M | 51.5M | 50.58M | 48.06M | 46.52M | 46.54M | 47.68M | 48.08M | 49.9M | 51.98M | 50.83M | 46.9M | 41.88M | 48.21M |
Cost of Revenue | 17.83M | 18.37M | 18.56M | 17.24M | 17.17M | 17.14M | 17.87M | 18.03M | 18.39M | 20.48M | 20.83M | 21.46M | 21.28M | 19.91M | 19.39M | 17.45M | 17.22M | 16.45M | 14.99M | 14.41M | 12.99M | 12.06M |
Gross Profit | 36.26M | 31.9M | 25.99M | 26.16M | 26.96M | 37.09M | 39.69M | 40.87M | 39.97M | 31.02M | 29.75M | 26.6M | 25.24M | 26.64M | 28.29M | 30.63M | 32.68M | 35.53M | 35.84M | 32.49M | 28.89M | 36.14M |
Operating Income | -52.75M | -55.89M | -71.05M | -55.79M | -52.6M | -41.18M | -30.77M | -21.1M | -15.19M | -19.45M | -15.1M | -21.9M | -28.38M | -36.93M | -42.07M | -43.02M | -42.14M | -35.89M | -34.68M | -38.66M | -44.47M | -37.56M |
Interest Income | 882K | n/a | n/a | 734K | 1.71M | 3.11M | 3.44M | 2.87M | 3.4M | 2.14M | 16.32M | 16.22M | 14.71M | 14.62M | 102K | 172K | 167K | 508K | 508K | 377K | 385K | 30K |
Pretax Income | -78.23M | -68.91M | -83.78M | -68.99M | -65.06M | -54.25M | -44.15M | -35.09M | -25.76M | -28.52M | -7.63M | -11.97M | -22.33M | -33.12M | -54.41M | -71M | -73.02M | -69.09M | -70.54M | -61.96M | -63.96M | -53.93M |
Net Income | -78.23M | -68.91M | -83.78M | -68.98M | -65.04M | -54.24M | -44.14M | -35.19M | -25.72M | -28.77M | -7.87M | -12.11M | -22.61M | -33.12M | -54.41M | -71M | -73.02M | -69.09M | -70.54M | -61.96M | -63.96M | -53.93M |
Selling & General & Admin | 73.11M | 71.75M | 79.85M | 63.04M | 59.91M | 58.56M | 50.18M | 43.72M | 38.98M | 34.98M | 31.75M | 34.01M | 39.09M | 47.31M | 52.88M | 56.05M | 55.72M | 53.27M | 53.48M | 54.08M | 53.75M | 54.51M |
Research & Development | 15.89M | 16.04M | 17.19M | 18.91M | 19.65M | 19.71M | 20.28M | 18.25M | 16.18M | 15.49M | 13.1M | 14.49M | 14.53M | 16.26M | 17.48M | 17.6M | 19.1M | 18.16M | 17.05M | 17.07M | 19.61M | 19.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 89M | 87.79M | 97.04M | 81.95M | 79.56M | 78.27M | 70.46M | 61.97M | 55.16M | 50.47M | 44.85M | 48.51M | 53.62M | 63.57M | 70.36M | 73.65M | 74.82M | 71.43M | 70.52M | 71.15M | 73.36M | 73.7M |
Interest Expense | 16.32M | 16.76M | 17.1M | 17.05M | 16.98M | 16.9M | 16.82M | 15.83M | 12.94M | 10.18M | 7.46M | 5.93M | 8.31M | 10.45M | 12.45M | 14.33M | 17.23M | 19.88M | 22.55M | 23.68M | 19.87M | 16.4M |
Selling & Marketing Expenses | 2.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 969K | 969K | 969K |
Cost & Expenses | 106.83M | 106.16M | 115.6M | 99.19M | 96.73M | 95.41M | 88.33M | 80M | 73.55M | 70.96M | 65.69M | 69.96M | 74.9M | 83.48M | 89.75M | 91.1M | 92.04M | 87.87M | 85.51M | 85.56M | 86.35M | 85.76M |
Income Tax Expense | n/a | n/a | n/a | -14K | -14K | -14K | -14K | 101K | -39K | 245K | 245K | 144K | 284K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 124.99M | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 55.63M | 54.39M | 53.42M | 45.28M | 41.31M | 40.39M | 39.22M | 37.07M | 35.56M |
Shares Outstanding (Diluted) | 124.99M | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 73.79M | 54.39M | 53.42M | 45.46M | 41.47M | 40.39M | 39.22M | 37.07M | 35.56M |
EPS (Basic) | -0.65 | -0.61 | -0.78 | -0.71 | -0.70 | -0.59 | -0.52 | -0.45 | -0.35 | -0.42 | 0.10 | -0.11 | -0.31 | -0.65 | -1.40 | -1.79 | -1.93 | -1.82 | -1.83 | -1.71 | -1.83 | -1.57 |
EPS (Diluted) | -0.65 | -0.61 | -0.78 | -0.71 | -0.70 | -0.59 | -0.52 | -0.45 | -0.35 | -0.42 | 0.01 | -0.20 | -0.40 | -0.74 | -1.40 | -1.79 | -1.93 | -1.82 | -1.83 | -1.71 | -1.83 | -1.57 |
EBITDA | -61.27M | -51.63M | -66.14M | -51.38M | -47.5M | -36.71M | -26.62M | -18.23M | -11.68M | -17.13M | 1.18M | -4.77M | -12.41M | -20.69M | -39.58M | -53.95M | -52.93M | -46.27M | -45.03M | -34.94M | -40.83M | -34.22M |
EBIT | -61.91M | -52.15M | -66.68M | -51.94M | -48.08M | -37.36M | -27.33M | -19.26M | -12.82M | -18.35M | -163K | -6.04M | -14.02M | -22.67M | -41.96M | -56.67M | -55.79M | -49.21M | -47.99M | -38.28M | -44.08M | -37.53M |
Depreciation & Amortization | 637K | 528K | 548K | 565K | 585K | 650K | 718K | 1.04M | 1.14M | 1.22M | 1.34M | 1.27M | 1.61M | 1.99M | 2.39M | 2.72M | 2.86M | 2.93M | 2.96M | 3.34M | 3.25M | 3.31M |
Add to Watchlist
Select watchlists to add or remove AQST